Skip Navigation

JNCI Journal of the National Cancer Institute 2001 93(23):1761; doi:10.1093/jnci/93.23.1761-b
© 2001 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Arnold, K.
Right arrow Articles by Eckstein, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Arnold, K.
Right arrow Articles by Eckstein, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 93, No. 23, 1761, December 5, 2001
© 2001 Oxford University Press

MEMORANDUM FOR: Science Writers and Editors on the Journal Press List

Paclitaxel Related to Increased Risk of Lung Inflammation in Women Receiving Radiation for Breast Cancer

November 29, 2001 (EMBARGOED FOR RELEASE 4 P.M. EST December 4)

Katherine Arnold, Deputy News Editor, Dan Eckstein, (301) 986-1891, ext. 112

Adding paclitaxel to standard chemotherapy greatly increases the risk that women also receiving radiation treatment for breast cancer will develop pneumonitis (inflammation) of the lungs.

A common course of treatment for breast cancer with positive lymph nodes is surgery followed by sequential or concurrent chemotherapy and radiation therapy. Paclitaxel is often added to . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?